Infants exposed to opioids and psychotropic drugs during pregnancy have a 30% to 60% higher risk of experiencing neonatal withdrawal, a study has found. That risk doubles when multiple psychotropic ...
Although the number of infants diagnosed with neonatal opioid withdrawal syndrome (NOWS) and the number of infants entering foster care have increased substantially in the US since 2009, analyses ...
A new study sheds light on two factors that affect the outcomes for infants with neonatal opioid withdrawal syndrome (NOWS). The article, "Transfer timing and the length of medication weaning for ...
Rates of neonatal abstinence syndrome surged in recent years, but a newer approach to caring for newborn babies exposed to opioids during pregnancy gets them out of the hospital sooner and with less ...
Maternal nonnarcotic analgesic allergy labels are linked to a 60% higher risk for eclampsia and 20% higher risk for preterm ...
Neonatal withdrawal signs have been documented in newborns of mothers treated with antidepressants and are known as a cause of neonatal morbidity. Due to the lack of a common terminology, withdrawal ...
Pediatric researchers at the University of Kentucky found that clonidine, an antihypertensive drug typically used to treat high blood pressure, can be as effective as morphine in treating neonatal ...
On learning last year she was pregnant with her second child, Cailyn Morreale was overcome with fear and trepidation. “I was so scared,” said Morreale, a resident of the small western North Carolina ...
The woman had used oxycodone for almost a decade but told her doctors she had been sober for two years. She never touched narcotics during her pregnancy, she said, and had completed rehab. But her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results